CN Patent

CN118772230A — 一种长效κ阿片受体激动剂

Assigned to Chengdu Aoda Biotechnology Co Ltd · Expires 2024-10-15 · 2y expired

What this patent protects

本发明涉及医药合成领域，公开了一种长效Κ阿片受体激动剂。本发明所述长效Κ阿片受体激动剂，用于制备治疗疾病的药物组合物，所述药物组合物用于缓解患者中度至重度瘙痒和用于术后镇痛。

USPTO Abstract

本发明涉及医药合成领域，公开了一种长效Κ阿片受体激动剂。本发明所述长效Κ阿片受体激动剂，用于制备治疗疾病的药物组合物，所述药物组合物用于缓解患者中度至重度瘙痒和用于术后镇痛。

Drugs covered by this patent

difelikefalin-acetate (DIFELIKEFALIN ACETATE)

Patent Metadata

Patent number: CN118772230A
Jurisdiction: CN
Classification: —
Expires: 2024-10-15
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Aoda Biotechnology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.